VIATREXX-CONNECTISSUE- anti-interleukin-1.alpha. immunoglobulin g rabbit, ascorbic acid, metenkefalin, ersofermin, bos taurus ca

Nazione: Stati Uniti

Lingua: inglese

Fonte: NLM (National Library of Medicine)

Compra

Scarica Scheda tecnica (SPC)
19-03-2019

Principio attivo:

Anti-Interleukin-1.Alpha. Immunoglobulin G Rabbit (UNII: ML4QRZ1HCL) (Anti-Interleukin-1.Alpha. Immunoglobulin G Rabbit - UNII:ML4QRZ1HCL), Ascorbic Acid (UNII: PQ6CK8PD0R) (Ascorbic Acid - UNII:PQ6CK8PD0R), Bos Taurus Red Blood Cell (UNII: 5W4FLB0U2C) (Bos Taurus Red Blood Cell - UNII:5W4FLB0U2C), Metenkefalin (UNII: 9JEZ9OD3AS) (Metenkefalin - UNII:9JEZ9OD3AS), Basic Fibroblast Growth Factor (Human) (UNII: S3529G9M9V) (Basic Fibroblast Growth Factor (Human) - UNII:S3529G9M9V), Sus Scrofa Cartilage (UNII:

Commercializzato da:

VIATREXX BIO INCORPORATED

Via di somministrazione:

INTRAVENOUS

Tipo di ricetta:

PRESCRIPTION DRUG

Indicazioni terapeutiche:

Viatrexx-Connectissue a sterile, injectable, biodegradable, clear isotonic liquid that is injected into the various layers of the skin, muscles, ligaments, joints, other body tissues or added to an IV, either as a push or into the bag. This product should not be used in patients with a known hypersensitivity to any ingredient found in the formula, porcine or beef products, isotonic saline or benzyl alcohol, or patients with a history of severe allergies. As with all injections, epinephrine injection (1:1,000) must be immediately available should an acute anaphylactoid reaction occur due to any component of the injection. This product contains 1% Benzyl Alcohol. Benzyl Alcohol has been reported to be associated with a fatal "Gasping Syndrome" in premature infants. Due to the benzyl alcohol content, this product should not be given to a pregnant woman. This product should not be used in patients with a known hypersensitivity to any ingredient in this formula, porcine products, isotonic saline or benzyl alcohol

Stato dell'autorizzazione:

unapproved drug other

Scheda tecnica

                                VIATREXX-CONNECTISSUE- ANTI-INTERLEUKIN-1.ALPHA. IMMUNOGLOBULIN G
RABBIT, ASCORBIC ACID,
METENKEFALIN, ERSOFERMIN, BOS TAURUS CARTILAGE, SUS SCROFA CARTILAGE,
PORK COLLAGEN, BOS TAURUS
RED BLOOD CELL, SUS SCROFA RED BLOOD CELL, INTERLEUKIN-3,
INTERLEUKIN-3, BEEF LIVER, PORK LIVER, BEEF,
PORK, BOS TAURUS TENDON, SUS SCROFA TENDON, CETERMIN INJECTION
VIATREXX BIO INCORPORATED
_Disclaimer: This drug has not been found by FDA to be safe and
effective, and this labeling has not been_
_approved by FDA. For further information about unapproved drugs,
click here._
----------
CONNECTIS S UE
10 mL
Rx
Sterile multi-dose injectable homeopathic vials
Isotonic saline with 1% Benzyl alcohol as a preservative.
For IM, IV, SC, Parenteral use.
Osmolarity around 0.3mOsmol/mL.
DES CRIPTION
VIATREXX-CONNECTISSUE is a homeopathic product composed of
physiological (low dose and low low
dose) natural micro nutrients. These nano particles are designed to
nourish the system.
INDICATIONS AND USE
VIATREXX-CONNECTISSUEa sterile, injectable, biodegradable, clear
isotonic liquid that is injected into the
various layers of the skin, muscles, ligaments, joints, other body
tissues or added to an IV, either as a
push or into the bag.
CONTRAINDICATIONS
This product should not be used in patients with a known
hypersensitivity to any ingredient found in the
formula, porcine or beef products, isotonic saline or benzyl alcohol,
or patients with a history of
severe allergies. As with all injections, epinephrine injection
(1:1,000) must be immediately available
should an acute anaphylactoid reaction occur due to any component of
the injection.
WARNINGS
Homeopathic injections are quite safe, but all medical procedures
carry some risk. The most common
risk is an allergic reaction to the injection of any ingredient found
in the formula, porcine, beef, benzyl
alcohol &/or saline. Do not use if allergic to any of these
substances. Side effects include some risk of
bruising and temporary redness at the site of the injection. Use
appropriate emergency protocol 
                                
                                Leggi il documento completo